June 28, 2021
WATERTOWN, MA – Captivate Bio, a scientific cell culture solutions provider, today announced it has signed an exclusive distribution agreement with PL BioScience GmbH, a biotech company located in Aachen, Germany, to bring its portfolio of human platelet lysate to markets across North America. PL BioScience GmbH produces human-derived platelet lysate (HPL), a growth factor-rich supplement used for growing and expanding cells for applications such as cell therapy and tissue engineering. Human platelet lysate serves as a replacement for animal-derived serum, such as fetal bovine serum (FBS).
June 17, 2021
Agreement expands reach of cell culture and cytogenetic reagents for researchers and clinicians in the US.
WATERTOWN, MA – Captivate Bio, a scientific cell culture solutions provider, today announced it has signed a non-exclusive agreement with Biological Industries Israel Beit Haemek Ltd, now part of the Sartorius Group, to distribute its portfolio of cell culture and cytogenetic reagents in the United States. Under the terms, Captivate Bio will focus on expanding its reach, with unique products including the EZ-PCR™ Mycoplasma Detection Kit for detecting cell culture contamination and products used for the analysis of amniotic fluid, chorionic villus, peripheral blood, bone marrow and hematopoietic cells. Products will begin shipping in September.
April 06, 2021
Captivate Bio Signs Agreement with denovoMATRIX GmbH, Offering Enabling Technologies for Cell Manufacturing
Captivate Bio to become North American distributor of modular, biomimetic cell culture products for cell therapy and cellular agriculture markets.
WATERTOWN, MA – Captivate Bio, a scientific cell culture solutions provider headquartered in Watertown, Massachusetts, announced today it has signed a distribution agreement with denovoMATRIX GmbH, a biotechnology company located in Dresden, Germany which designs modular, biomimetic coatings for adherent cell manufacturing. Captivate Bio will become the North American distributor of myMATRIX products including the innovative screenMATRIX and myMATRIX MSC as well as the newly released myMATRIX iPSC cultureware.
January 14, 2021
Startup is championing localized manufacturing in the fight against Coronavirus and future diseases.
WATERTOWN, MA – Captivate Bio, a newly formed scientific solutions provider headquartered in Watertown, Massachusetts, emerged from stealth mode today to announce it has successfully launched its portfolio of cell culture tools to assist in the fight against COVID-19 and other emerging diseases as well as help address the gaps exposed by supply chain issues and delays in cell culture media manufacturing here in the United States.